Vanguard disaggregates holdings; CYRX shows 0 shares after realignment (CYRX)
Rhea-AI Filing Summary
CryoPort Inc — Schedule 13G/A (Amendment No. 7): The Vanguard Group reports zero shares beneficially owned of CryoPort Inc common stock, representing 0% of the class. The filing explains an internal realignment at The Vanguard Group on January 12, 2026, after which certain subsidiaries now report holdings separately.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings; no beneficial ownership reported for CryoPort.
The filing states The Vanguard Group completed an internal realignment on January 12, 2026 and, under SEC Release No. 34-39538, certain subsidiaries now report separately. The reported beneficial ownership for CryoPort common stock is 0 shares (0%).
Cash‑flow treatment or sale activity is not disclosed in this excerpt; subsequent filings by Vanguard's subsidiaries may show any beneficial positions. The disclosure clarifies reporting structure rather than indicating active purchases or sales.
Amendment is administrative, reflecting SEC guidance on disaggregated reporting.
The text cites SEC Release No. 34-39538 to justify separate reporting by subsidiaries that pursue the same investment strategies previously reported under The Vanguard Group, Inc. This is a procedural reallocation of reporting responsibility.
For investors, the key fact is the reported 0 shares (0%) position in this filing; any material holdings now reside in separate subsidiary filings.
AI-generated analysis. How Rhea-AI works. Not financial advice.